First participant dosed with novel investigational EBV vaccine targeting multiple viral proteins in Phase I study ...

Merck has just released a cyber-to-physical platform that uses crypto anchor technology and other tools to help crush the counterfeit product market.

M-Trust™ is a secure cyber-physical trust platform that enables the creation of digital twins for enhanced product quality ...

WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...

WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

Viking Therapeutics ( VKTX 4.30%) didn't exactly capture investors' hearts in the final month of 2024. The biotech company's ...

Halozyme provides subcutaneous drug delivery solutions, with several major new products recently approved. Click here to find ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.